184 related articles for article (PubMed ID: 27327043)
1. The impact of a male or female thrombotic family history on contraceptive counseling: a cohort study.
van Vlijmen EF; Veeger NJ; Middeldorp S; Hamulyák K; Prins MH; Kluin-Nelemans HC; Meijer K
J Thromb Haemost; 2016 Sep; 14(9):1741-8. PubMed ID: 27327043
[TBL] [Abstract][Full Text] [Related]
2. Combined oral contraceptives, thrombophilia and the risk of venous thromboembolism: a systematic review and meta-analysis.
van Vlijmen EF; Wiewel-Verschueren S; Monster TB; Meijer K
J Thromb Haemost; 2016 Jul; 14(7):1393-403. PubMed ID: 27121914
[TBL] [Abstract][Full Text] [Related]
3. Thrombotic risk during oral contraceptive use and pregnancy in women with factor V Leiden or prothrombin mutation: a rational approach to contraception.
van Vlijmen EF; Veeger NJ; Middeldorp S; Hamulyák K; Prins MH; Büller HR; Meijer K
Blood; 2011 Aug; 118(8):2055-61; quiz 2375. PubMed ID: 21659542
[TBL] [Abstract][Full Text] [Related]
4. Oral contraceptives and the absolute risk of venous thromboembolism in women with single or multiple thrombophilic defects: results from a retrospective family cohort study.
van Vlijmen EF; Brouwer JL; Veeger NJ; Eskes TK; de Graeff PA; van der Meer J
Arch Intern Med; 2007 Feb; 167(3):282-9. PubMed ID: 17296885
[TBL] [Abstract][Full Text] [Related]
5. Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen.
Bloemenkamp KW; Rosendaal FR; Helmerhorst FM; Büller HR; Vandenbroucke JP
Lancet; 1995 Dec; 346(8990):1593-6. PubMed ID: 7500751
[TBL] [Abstract][Full Text] [Related]
6. Can a change in screening and prescribing practice reduce the risk of venous thromboembolism in women taking the combined oral contraceptive pill?
Mills A; Wilkinson C; Fotherby K
Br J Fam Plann; 1998 Jan; 23(4):112-5. PubMed ID: 9882763
[TBL] [Abstract][Full Text] [Related]
7. Combined hormonal contraceptive use among women with known dyslipidemias: a systematic review of critical safety outcomes.
Dragoman M; Curtis KM; Gaffield ME
Contraception; 2016 Sep; 94(3):280-7. PubMed ID: 26272309
[TBL] [Abstract][Full Text] [Related]
8. Combined hormonal contraceptive use among obese women and risk for cardiovascular events: A systematic review.
Horton LG; Simmons KB; Curtis KM
Contraception; 2016 Dec; 94(6):590-604. PubMed ID: 27263039
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for venous thromboembolism in women under combined oral contraceptive. The PILl Genetic RIsk Monitoring (PILGRIM) Study.
Suchon P; Al Frouh F; Henneuse A; Ibrahim M; Brunet D; Barthet MC; Aillaud MF; Venton G; Alessi MC; Trégouët DA; Morange PE
Thromb Haemost; 2016 Jan; 115(1):135-42. PubMed ID: 26290123
[TBL] [Abstract][Full Text] [Related]
10. Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study.
Wu O; Robertson L; Twaddle S; Lowe GD; Clark P; Greaves M; Walker ID; Langhorne P; Brenkel I; Regan L; Greer I
Health Technol Assess; 2006 Apr; 10(11):1-110. PubMed ID: 16595080
[TBL] [Abstract][Full Text] [Related]
11. Population-based study of risk of venous thromboembolism associated with various oral contraceptives.
Farmer RD; Lawrenson RA; Thompson CR; Kennedy JG; Hambleton IR
Lancet; 1997 Jan; 349(9045):83-8. PubMed ID: 8996419
[TBL] [Abstract][Full Text] [Related]
12. Oral contraception in women with mild thrombophilia: what have we learned recently?
Blanco-Molina Á
Thromb Res; 2012 Oct; 130 Suppl 1():S16-8. PubMed ID: 23026651
[TBL] [Abstract][Full Text] [Related]
13. Long-term risk of recurrent venous thromboembolism after a first contraceptive-related event: Data from REVERSE cohort study.
Aziz D; Skeith L; Rodger MA; Sabri E; Righini M; Kovacs MJ; Carrier M; Kahn SR; Wells PS; Anderson DR; Chagnon I; Solymoss S; Crowther MA; White RH; Le Gal G
J Thromb Haemost; 2021 Jun; 19(6):1526-1532. PubMed ID: 33724705
[TBL] [Abstract][Full Text] [Related]
14. Incidence of venous thromboembolism in first-degree relatives of patients with venous thromboembolism who have factor V Leiden.
Couturaud F; Kearon C; Leroyer C; Mercier B; Abgrall JF; Le Gal G; Lacut K; Oger E; Bressollette L; Ferec C; Lamure M; Mottier D;
Thromb Haemost; 2006 Dec; 96(6):744-9. PubMed ID: 17139368
[TBL] [Abstract][Full Text] [Related]
15. Do incident and recurrent venous thromboembolism risks truly differ between heterozygous and homozygous Factor V Leiden carriers? A retrospective cohort study.
Perez Botero J; Ormsby WD; Ashrani AA; McBane RD; Wysokinski WE; Patnaik MM; Lewis BR; Grill DE; Pruthi RK; Heit JA
Eur J Intern Med; 2016 May; 30():77-81. PubMed ID: 26970916
[TBL] [Abstract][Full Text] [Related]
16. Venous Thromboembolism in Women of Childbearing Age: Insights from the START Registry.
Grandone E; Antonucci E; Colaizzo D; De Laurenzo A; Cosmi B; Cini M; Legnani C; Testa S; Margaglione M; Palareti G
Thromb Haemost; 2023 Nov; 123(11):1060-1068. PubMed ID: 37263294
[TBL] [Abstract][Full Text] [Related]
17. Risk of venous thromboembolism with drospirenone in combined oral contraceptive products.
Sehovic N; Smith KP
Ann Pharmacother; 2010 May; 44(5):898-903. PubMed ID: 20371756
[TBL] [Abstract][Full Text] [Related]
18. In families with inherited thrombophilia the risk of venous thromboembolism is dependent on the clinical phenotype of the proband.
Rossi E; Ciminello A; Za T; Betti S; Leone G; De Stefano V
Thromb Haemost; 2011 Oct; 106(4):646-54. PubMed ID: 21833444
[TBL] [Abstract][Full Text] [Related]
19. Prothrombin 20210A mutation: a mild risk factor for venous thromboembolism but not for arterial thrombotic disease and pregnancy-related complications in a family study.
Bank I; Libourel EJ; Middeldorp S; Van Pampus EC; Koopman MM; Hamulyák K; Prins MH; Van Der Meer J; Büller HR
Arch Intern Med; 2004 Sep; 164(17):1932-7. PubMed ID: 15451770
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
